- Home
- / Five Prime Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Five Prime Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$13.2 M
FY, 2020
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 49.9M | 14.9M | 13.2M |
| General and administrative expense | 39.7M | 42.7M | 40.6M |
| Operating expense total | 196.0M | 156.8M | 106.0M |
| EBIT | (146.2M) | (141.9M) | (92.9M) |
| EBIT margin, % | -293.1% | -954.3% | -704.7% |
| Interest income | 5.8M | 4.7M | 820.0K |
| Pre tax profit | (140.4M) | (137.2M) | (91.0M) |
| Income tax expense | (6.6M) | ||
| Net Income | (140.4M) | (137.2M) | (84.3M) |
| EPS | (4.1) | (3.9) | (2.3) |